Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 119

Similar articles for PubMed (Select 23296375)

1.

Low NDRG1 mRNA expression predicts a poor prognosis in neuroblastoma patients.

Matsushita K, Uchida K, Saigusa S, Ide S, Hashimoto K, Koike Y, Otake K, Inoue M, Tanaka K, Kusunoki M.

Pediatr Surg Int. 2013 Apr;29(4):363-8. doi: 10.1007/s00383-012-3248-6.

PMID:
23296375
3.

NDRG1 as a biomarker for metastasis, recurrence and of poor prognosis in hepatocellular carcinoma.

Cheng J, Xie HY, Xu X, Wu J, Wei X, Su R, Zhang W, Lv Z, Zheng S, Zhou L.

Cancer Lett. 2011 Nov 1;310(1):35-45. doi: 10.1016/j.canlet.2011.06.001. Epub 2011 Jun 24.

PMID:
21763068
4.

[Study on MYCN gene amplification and CD44 expression in neuroblastoma].

Hu HL, He LJ.

Zhonghua Bing Li Xue Za Zhi. 2004 Aug;33(4):332-6. Chinese.

PMID:
15363318
5.

Immunohistochemical expressions of Cap43 and Mina53 proteins in neuroblastoma.

Fukahori S, Yano H, Tsuneoka M, Tanaka Y, Yagi M, Kuwano M, Tajiri T, Taguchi T, Tsuneyoshi M, Kojiro M.

J Pediatr Surg. 2007 Nov;42(11):1831-40.

PMID:
18022432
6.

Expression of a MYCN-interacting isoform of the tumor suppressor BIN1 is reduced in neuroblastomas with unfavorable biological features.

Tajiri T, Liu X, Thompson PM, Tanaka S, Suita S, Zhao H, Maris JM, Prendergast GC, Hogarty MD.

Clin Cancer Res. 2003 Aug 15;9(9):3345-55.

7.

NDRG1/Cap43/Drg-1 may predict tumor angiogenesis and poor outcome in patients with lung cancer.

Azuma K, Kawahara A, Hattori S, Taira T, Tsurutani J, Watari K, Shibata T, Murakami Y, Takamori S, Ono M, Izumi H, Kage M, Yanagawa T, Nakagawa K, Hoshino T, Kuwano M.

J Thorac Oncol. 2012 May;7(5):779-89. doi: 10.1097/JTO.0b013e31824c92b4.

PMID:
22481237
8.

Regulation of MYCN expression in human neuroblastoma cells.

Jacobs JF, van Bokhoven H, van Leeuwen FN, Hulsbergen-van de Kaa CA, de Vries IJ, Adema GJ, Hoogerbrugge PM, de Brouwer AP.

BMC Cancer. 2009 Jul 18;9:239. doi: 10.1186/1471-2407-9-239.

9.

Relationship of DDX1 and NAG gene amplification/overexpression to the prognosis of patients with MYCN-amplified neuroblastoma.

Kaneko S, Ohira M, Nakamura Y, Isogai E, Nakagawara A, Kaneko M.

J Cancer Res Clin Oncol. 2007 Mar;133(3):185-92. Epub 2006 Oct 7.

PMID:
17028906
10.

Prognostic value of NDRG1 and SPARC protein expression in breast cancer patients.

Nagai MA, Gerhard R, Fregnani JH, Nonogaki S, Rierger RB, Netto MM, Soares FA.

Breast Cancer Res Treat. 2011 Feb;126(1):1-14. doi: 10.1007/s10549-010-0867-2. Epub 2010 Apr 6.

PMID:
20369286
11.

Co-amplification and concomitant high levels of expression of a DEAD box gene with MYCN in human neuroblastoma.

Manohar CF, Salwen HR, Brodeur GM, Cohn SL.

Genes Chromosomes Cancer. 1995 Nov;14(3):196-203.

PMID:
8589036
12.

Insulin-like growth factor II mRNA-binding protein 3 expression predicts unfavorable prognosis in patients with neuroblastoma.

Chen ST, Jeng YM, Chang CC, Chang HH, Huang MC, Juan HF, Hsu CH, Lee H, Liao YF, Lee YL, Hsu WM, Lai HS.

Cancer Sci. 2011 Dec;102(12):2191-8. doi: 10.1111/j.1349-7006.2011.02100.x. Epub 2011 Oct 17.

PMID:
21917080
13.

Decreased expression of NDRG1 is correlated with tumor progression and poor prognosis in patients with esophageal squamous cell carcinoma.

Ando T, Ishiguro H, Kimura M, Mitsui A, Kurehara H, Sugito N, Tomoda K, Mori R, Takashima N, Ogawa R, Fujii Y, Kuwabara Y.

Dis Esophagus. 2006;19(6):454-8.

PMID:
17069588
14.

Overexpression of NDRG1 is an indicator of poor prognosis in hepatocellular carcinoma.

Chua MS, Sun H, Cheung ST, Mason V, Higgins J, Ross DT, Fan ST, So S.

Mod Pathol. 2007 Jan;20(1):76-83. Epub 2006 Sep 29.

15.

Expression of inhibitor-of-apoptosis protein (IAP) livin by neuroblastoma cells: correlation with prognostic factors and outcome.

Kim DK, Alvarado CS, Abramowsky CR, Gu L, Zhou M, Soe MM, Sullivan K, George B, Schemankewitz E, Findley HW.

Pediatr Dev Pathol. 2005 Nov-Dec;8(6):621-9. Epub 2005 Nov 18.

PMID:
16328668
16.

Increased NDRG1 expression is associated with advanced T stages and poor vascularization in non-small cell lung cancer.

Fan C, Yu J, Liu Y, Xu H, Wang E.

Pathol Oncol Res. 2012 Jul;18(3):549-56. doi: 10.1007/s12253-010-9294-2. Epub 2010 Sep 18.

PMID:
20853080
17.

Significance of survivin mRNA expression in prognosis of neuroblastoma.

Ito R, Asami S, Motohashi S, Ootsuka S, Yamaguchi Y, Chin M, Shichino H, Yoshida Y, Nemoto N, Mugishima H, Suzuki T.

Biol Pharm Bull. 2005 Apr;28(4):565-8.

18.

Epithelial-mesenchymal transition-related gene expression as a new prognostic marker for neuroblastoma.

Nozato M, Kaneko S, Nakagawara A, Komuro H.

Int J Oncol. 2013 Jan;42(1):134-40. doi: 10.3892/ijo.2012.1684. Epub 2012 Nov 6.

19.

N-myc downstream regulated gene-1/Cap43 may play an important role in malignant progression of prostate cancer, in its close association with E-cadherin.

Song Y, Oda Y, Hori M, Kuroiwa K, Ono M, Hosoi F, Basaki Y, Tokunaga S, Kuwano M, Naito S, Tsuneyoshi M.

Hum Pathol. 2010 Feb;41(2):214-22. doi: 10.1016/j.humpath.2009.07.011. Epub 2009 Oct 1.

PMID:
19800102
20.

Expression of B-myb in neuroblastoma tumors is a poor prognostic factor independent from MYCN amplification.

Raschellà G, Cesi V, Amendola R, Negroni A, Tanno B, Altavista P, Tonini GP, De Bernardi B, Calabretta B.

Cancer Res. 1999 Jul 15;59(14):3365-8.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk